Form D · Pharmaceuticals
China Biologic Products, Inc.
Tai'an City, Shandong, F4 · CIK 0001369868
Offering snapshot reported Jun 26, 2009 · SEC filing
- Reported sold
- $9.55M Offering amount: $9.55M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $122K Reported outside-investor minimum
- First sale
- Jun 10, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2009 | Initial | $9,554,140 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $587K
- Finders' fees
- $0
- Form D file number
- 021-132294
The transaction fee is based on 7% of the new investors' capital of $7,500,000 and 3% of the existing investors' capital of $2,054,140.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Oppenheimer & Co. Inc. | 249 |
Source: Form D, filed Jun 26, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Siu Ling Chan | Director |
| Jie Gan | Director |
| Yun Yun Tristan Kuo | Executive |
| Ling Lin Li | Director |
| Tong Jun Lin | Director |
| Sean Shao | Director |
| Chao Ming Zhao | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
No.14 East Hushan Road
Tai'an City, Shandong, F4, 271000
Tai'an City, Shandong, F4, 271000